R. Collins

Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.

J. Clive, P A Benn, J M Clive, 1997, Clinical chemistry.

Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.

A. Borgida, J. Rodis, P. Benn, 1997, American journal of obstetrics and gynecology.

Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols.

J. Rodis, P. Benn, T. Beazoglou, 1999, Obstetrics and gynecology.

MATERNAL BRAIN DEATH AND PROLONGED FETAL SURVIVAL

P. Catalano, I. Bernstein, G. Davis, 1989, Obstetrics and gynecology.

Maternal brain death and prolonged fetal survival.

P. Catalano, I. Bernstein, G. Davis, 1989, Obstetrics and gynecology.

Incorporation of Inhibin‐A in Second‐Trimester Screening for Down Syndrome

J. Egan, P. Benn, M. Fang, 2003, Obstetrics and gynecology.

Maternal serum screening for birth defects: results of a Connecticut regional program.

R. Greenstein, P. Benn, A. Craffey, 1996, Connecticut medicine.